Swiss Archives of Neurology and Psychiatry最新文献

筛选
英文 中文
Unchanged incidence and prevalence of amyotrophic lateral sclerosis in the canton of Zürich. zrich州肌萎缩性侧索硬化症的发病率和患病率不变。
S Huber, V Henn
{"title":"Unchanged incidence and prevalence of amyotrophic lateral sclerosis in the canton of Zürich.","authors":"S Huber,&nbsp;V Henn","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The incidence and prevalence of amyotrophic lateral sclerosis (ALS) was determined for the canton of Zürich over the ten year period 1981-1990. The annual incidence rate was found to be 0.92 per 100,000 population, while the prevalence rate was 3.88 per 100,000 population, with a preponderance for males. Strong yearly fluctuations in the number of newly detected cases average out over the whole period with no trends of increased incidence. Data are within the range as reported from other industrialized countries.</p>","PeriodicalId":30134,"journal":{"name":"Swiss Archives of Neurology and Psychiatry","volume":"146 2","pages":"52-4"},"PeriodicalIF":0.0,"publicationDate":"1995-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18577443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Status of the discussion regarding cost-effectiveness of community psychiatry and inpatient psychiatry]. [关于社区精神病学和住院精神病学成本效益的讨论现状]。
H D Brenner
{"title":"[Status of the discussion regarding cost-effectiveness of community psychiatry and inpatient psychiatry].","authors":"H D Brenner","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In the current climate of escalating health care costs and shrinking resources, higher priority is also being given to the relation between costs and benefits of reform efforts and further developments of existing service delivery systems in the field of mental health. Some proponents of community psychiatry have predicted in a pointed manner that a change in the allocation of resources in favor of community-based care would dramatically decrease the need for hospital beds, cost half as much and be clinically at least as efficacious as inpatient treatment. The author gives careful consideration to these postulates based on today's available literature and on his own experiences in Mannheim and in Bern. He presents an array of newer findings which places them in perspective and to some extent contradicts them as well. Recent studies on the effects of an expansion of outpatient treatment programs on the overall mental health delivery system suggest that in areas with already reasonably developed community services its further enhancement rarely has an effect on the number of admissions to and length of hospital stays. In addition, the postulate that community care is considerably less costly only holds if in- and outpatient facilities are not considered to be integral parts of a comprehensive system of mental health care which both serve different purposes. Accordingly, the question of the effectiveness of treatment must also be discussed very distinctively. Although a network of well-functioning community-based services is (not yet) a veritable alternative, it can by all means, however, serve as a useful counterpart to the intensive treatment offered in modern mental institutions.(ABSTRACT TRUNCATED AT 250 WORDS)</p>","PeriodicalId":30134,"journal":{"name":"Swiss Archives of Neurology and Psychiatry","volume":"146 1","pages":"24-32"},"PeriodicalIF":0.0,"publicationDate":"1995-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18795530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Neuritis of multiple cranial nerves in idiopathic focal pachymeningitis]. 特发性局灶性厚脑膜炎的多颅神经炎。
P Pedrazzi, J P Deruaz, F Regli
{"title":"[Neuritis of multiple cranial nerves in idiopathic focal pachymeningitis].","authors":"P Pedrazzi,&nbsp;J P Deruaz,&nbsp;F Regli","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A 76 years old patient suffering from insulin dependent diabetes presents a multiple, bilateral and asymmetric cranial neuropathy involving on the left side the cranial nerves VIII, IX with a participation of the efferent autonomic fibers of the nerves VII and IX (xerostomia) and the nerve XII, and involving on both sides the nerves VII and X. Like it is known from literature the nerve XI was spared, probably because of the more caudal emergence from the brainstem. The disease was preceded by a violent otalgia on the left side which was initially interpretated as a malignant external otitis. This affection was associated with an inflammatory syndrome that was easily monitored by the blood sedimentation rate. The course was favorable but marked by fluctuations of the neurological deficits. The MRI shows a pachymeningitis localised at the beginning in the medial fossa and on the cerebellar tentorium, later on the left parieto-occipital convexity. The diagnosis of a focal idiopathic pachymeningitis was confirmed by excluding different other affections like inflammatory, tumoral and infectious diseases, by using MRI examinations, CSF analysis and especially meningeal biopsy. It is a rare inflammatory disease of unknown origin with potentially persistent neurological deficits. We discuss the differential diagnosis and the therapeutical possibilities, which consist in a long term immunosuppression with corticosteroids and azathioprine.</p>","PeriodicalId":30134,"journal":{"name":"Swiss Archives of Neurology and Psychiatry","volume":"146 6","pages":"270-6"},"PeriodicalIF":0.0,"publicationDate":"1995-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19833404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Schizophrenia and substance dependence]. [精神分裂症和物质依赖]。
A Uchtenhagen
{"title":"[Schizophrenia and substance dependence].","authors":"A Uchtenhagen","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A review of epidemiological data regarding the prevalence of substance abuse in schizophrenia and vice versa points out differences which are hard to interpret, owing to inconsistent sampling procedures and to the application of different diagnostic criteria. Stimulant abuse in schizophrenics has apparently increased over the years, eventually alcoholic abuse, whereas no increase is evidenced for cannabis abuse. Patients with dual diagnosis have an increased risk for morbidity and mortality, for psychotic relapse and for social disintegration. No increased risk for schizophrenic psychosis is found for drug abusers. Possible explanations why schizophrenics could show an increased susceptibility to become substance abusers are discussed, and therapeutic recommendations added.</p>","PeriodicalId":30134,"journal":{"name":"Swiss Archives of Neurology and Psychiatry","volume":"146 5","pages":"215-23"},"PeriodicalIF":0.0,"publicationDate":"1995-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19634247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The Bleuler tradition of the schizophrenia concept and Burghölzli as the site for psychotherapy of schizophrenic patients]. [精神分裂症概念的布鲁勒传统和Burghölzli作为精神分裂症患者心理治疗的网站]。
G Benedetti
{"title":"[The Bleuler tradition of the schizophrenia concept and Burghölzli as the site for psychotherapy of schizophrenic patients].","authors":"G Benedetti","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The author, who worked for many years with Manfred Bleuler, summarises the essence of Bleuler's theory of schizophrenia: that healthy and disturbed psychic processes occur simultaneously; an understanding of the complexity of the schizophrenic person; understanding the psychosis in relation to a persons life, which arises from a disposition that becomes manifest in the conflicts that life entails; the importance of psychotherapy and social care. The author shows how his own work contributed to this theory.</p>","PeriodicalId":30134,"journal":{"name":"Swiss Archives of Neurology and Psychiatry","volume":"146 5","pages":"195-9"},"PeriodicalIF":0.0,"publicationDate":"1995-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19634244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Recent developments in antipsychotic medication]. 抗精神病药物的最新进展。
H J Möller
{"title":"[Recent developments in antipsychotic medication].","authors":"H J Möller","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The development of new neuroleptics aims to reduce unwanted extrapyramidal motor side effects as well as the non-response rate, and to achieve a greater effect on negative symptoms. Preferential binding of neuroleptics to D2-receptors in the limbic system, as well as the combination of dopamine D2- and serotonin S2-antagonism proved to be effective. A potent D2-S2-antagonism as was realized with positive results in risperidone serves as a model for a whole class of new neuroleptics.</p>","PeriodicalId":30134,"journal":{"name":"Swiss Archives of Neurology and Psychiatry","volume":"146 5","pages":"230-9"},"PeriodicalIF":0.0,"publicationDate":"1995-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19634860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Psychotherapy with dyssocial patients]. [社会障碍患者的心理治疗]。
U Rauchfleisch
{"title":"[Psychotherapy with dyssocial patients].","authors":"U Rauchfleisch","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Psychotherapy of dissocial personalities is, even by psychotherapists, often judged sceptically. As obstacles are most of all mentioned the lack of motivation and the excessive acting out of these patients. Because of the development of the personality of dissocial people motivation in the ordinary sense can not be expected. But this does not mean that therapy is impossible. These patients are often rejected by therapists because they feel injured by the patients' rejection and by their devaluation of the therapeutic attention. We find the same dynamics concerning the excessive acting out or these patients. Problems in countertransference also arise because therapists must reduce their therapeutic ambitions and must be satisfied with improvements which-in their eyes-are negligible.</p>","PeriodicalId":30134,"journal":{"name":"Swiss Archives of Neurology and Psychiatry","volume":"146 3","pages":"115-20"},"PeriodicalIF":0.0,"publicationDate":"1995-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18492515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paroxetine in the treatment of inpatients with non-delusional endogenous or neurotic depression. 帕罗西汀治疗住院患者非妄想性内源性或神经性抑郁症。
M Wolfersdorf, T Barg, F König, M Leibfarth, I Grünewald, S Wetzel
{"title":"Paroxetine in the treatment of inpatients with non-delusional endogenous or neurotic depression.","authors":"M Wolfersdorf,&nbsp;T Barg,&nbsp;F König,&nbsp;M Leibfarth,&nbsp;I Grünewald,&nbsp;S Wetzel","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The clinical course of 35 depressed inpatients (19 women, 16 men; 19 endogenous, 16 neurotic depression (ICD-9 diagnoses); mean age 46.7 years) who were treated with paroxetine 20 mg/d was observed over 21 days using the Hamilton Depression Scale (HAMD). For both types of depression there was a significant decrease from day 1 to day 21 in the mean HAMD total score and in a subscore of cognitive and somatic items. The mean value of the HAMD suicide item increased in 3 cases and decreased in 25.</p>","PeriodicalId":30134,"journal":{"name":"Swiss Archives of Neurology and Psychiatry","volume":"145 6","pages":"15-8"},"PeriodicalIF":0.0,"publicationDate":"1994-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18539534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Social control, social support and therapy. The tension field of (social-)psychiatric treatment]. 社会控制,社会支持和治疗。(社会)精神病学治疗的张力场。
H Hoffmann
{"title":"[Social control, social support and therapy. The tension field of (social-)psychiatric treatment].","authors":"H Hoffmann","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>As generally in psychiatry the treatment concepts in social psychiatry base to a great extend on disease- and deficit models. These models, however, have their limits and run the risk to promote exactly that, what social psychiatry is fighting against: chronification. The question shall be discussed, if the systemic approach could be helpful to reduce (social) psychiatry's contribution on the process of chronification. Since ever psychiatric institutions have the mandate of social control and exclusion of social disturbing people from society. On the other hand, social support has become a cornerstone of rehabilitation in psychiatry. There the therapist becomes the manager of the disability. The (case-)manager subsequently takes over the responsibility for the future course. So he also gets power over the system to be treated. He decides, how much of social support and control is necessary. But then he gives up the aim of profoundly changing something in the sense that the patient can give up his symptoms and take more self-responsibility for his acting. The consequence is that the patient and psychiatry keep up each other: a coevolution develops. This leads to rigidity and makes changes difficult. By taking over responsibility the therapist becomes part of the system to be treated. So he looses his neutrality and also the possibility of therapeutical influence and change. The whole system quickly moves into a vicious circle of helplessness. Finally it will be reflected how someone, working in an institution, still can do therapy in this field of tension of (social) psychiatry.</p>","PeriodicalId":30134,"journal":{"name":"Swiss Archives of Neurology and Psychiatry","volume":"145 6","pages":"35-40"},"PeriodicalIF":0.0,"publicationDate":"1994-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18539538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expression patterns of human PNS myelin proteins in neuropathies associated with anti-myelin antibodies. 人PNS髓磷脂蛋白在与抗髓磷脂抗体相关的神经病中的表达模式。
J M Gabriel, B Erne, G C Miescher, J Ulrich, C Vital, A J Steck
{"title":"Expression patterns of human PNS myelin proteins in neuropathies associated with anti-myelin antibodies.","authors":"J M Gabriel,&nbsp;B Erne,&nbsp;G C Miescher,&nbsp;J Ulrich,&nbsp;C Vital,&nbsp;A J Steck","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":30134,"journal":{"name":"Swiss Archives of Neurology and Psychiatry","volume":"145 3","pages":"22-3"},"PeriodicalIF":0.0,"publicationDate":"1994-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18542505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书